Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chas Mckhann currently holds 45,000 shares of Apollo Endosurgery, Inc. (APEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chas Mckhann has been a net seller of APEN stock. They have purchased $0 and sold $1.0M worth of shares.
Chas Mckhann's most recent insider trade was on Jun 9, 2026, when they sold 37,500 shares at $0.00 per share.
Chas Mckhann serves as Executive at Apollo Endosurgery, Inc. (APEN). They have executed 16 insider transactions totaling $1.0M over their tenure at the company.
Chas Mckhann holds the position of Executive at Apollo Endosurgery, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Chas Mckhann has shown a selling trading pattern, with $0 in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Chas Mckhann was on May 5, 2022, when they sold $360.7K worth of APEN shares. This transaction involved 66,553 shares at $5.42 per share.
Chas Mckhann currently owns 45,000 shares of Apollo Endosurgery, Inc. (APEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chas Mckhann's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chas Mckhann has 16 Form 4 filings on record as an insider at Apollo Endosurgery, Inc..
Set alerts for Chas Mckhann and 40,000+ other insiders.